Whalewisdom has at least 157 form 4 filings the firm last filed a form d notice of exempt. The durham company disclosed in its annual report filed with the sec on. Samson ayana of argos therapeutics, durham contact samson ayana we use cookies to make interactions with our website easy and meaningful, to better understand the use of our services, and to. Aligos therapeutics is discovering and developing new classes of molecules that interact directly with diseasecausing modalities such as viral encoded proteins and nucleic acids, as well as oncogenes and their resultant proteins in the case of our cancer indications. Args will announce its third quarter financial results for the three months ended september 30, 2017, on november 9, 2017. Jeff abbey, ceo of argos therapeutics, says its important for developers to be smart about clinical trial design. Argos therapeutics inc argos therapeutics hires john d. Argos therapeutics is an immunooncology company focused on the development and commercialization of individualized immunotherapies for the treatment of. The next generation of cancer immunotherapy pharmavoice. Ags003 was manufactured at a centralized gmp compliant facility argos therapeutics, durham, nc.
Args argos, an immunooncology company focused on the development and commercialization of truly individualized. In a report published tuesday, stifel analyst joel sendek initiated coverage on argos therapeutics nasdaq. Argos therapeutics initiated the construction of a biomanufacturing facility at research triangle park in durham, north carolina nc, us, in october 2014. Argos therapeutics enters into strategic research agreement. Argos therapeutics a very small and growing company. About argos therapeutics argos therapeutics is an immunooncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer using. Argos therapeutics filed for chapter 11 protection in delaware on nov. The bankruptcy follows the termination of an unsuccessful phase 3 clinical trial of its most advanced cancertreatment product. The company has clinical trial programs in cancer and human immunodeficiency virus. Is this the end for durhams argos therapeutics nasdaq. Sep 18, 2017 argos therapeuticss fiveyear beta of 1. At yahoo finance, you get free stock quotes, uptodate news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. May 05, 2017 argos further stated in the filing that it is not currently in compliance with the audit committee requirement as a result of the resignation of dr.
Now, argos seeks to run a goingconcern sale process with cellscript, llc as a stalking horse buyer. View charles nicolettes profile on linkedin, the worlds largest professional community. Argos therapeutics reported last year revenue per employee of 8,888. Argos therapeutics found 101 250 employees, 6 phone numbers and 4 emails.
Argos therapeutics delivering precision immunotherapy. The companys stateoftheart laboratories and cgmp compliant cell processing facilities are located at. Wilmerhale advises argos therapeutics in asset sale to affiliate of. Argos therapeutics files bankruptcy to pursue a sale the. They treat their employees as valuable contributors to the company and not just a number or things.
Briefargos therapeutics files for possible resale up to 18. Compare pay for popular roles and read about the teams worklife balance. Samson ayana argos therapeutics, durham quality control. Durham, nc, april 02, 2018 globe newswire argos therapeutics, inc.
Args says it needs to raise capital to continue operations. Birner joined the munich office of tvm capital, a venture capital firm and affiliate of argos, as an investment manager in 2000 and currently serves as the managing partner of the firm. Birner served as head of european business development and director of marketing for germany at zeneca agrochemicals, a biopharmaceutical company. Argos therapeutics cellular manufacturing associate level ii former employee north carolina august 27, 2016 this position gave me handson experience with clinical trials, laboratory methods, fda pharmaceutical requirements, documentation, and technical writing. Args, an immunooncology company focused on the development and commercialization of individualized immunotherapies based on the arcelis. Argos therapeutics is a biopharmaceutical company which focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. We use cookies in order to provide you with a better browsing experience.
Args institutional ownership, buyers argos therapeutics, inc. Wilmerhale acted as lead counsel to immunotherapy company argos therapeutics, inc. Stifel initiates coverage on argos therapeutics on. Its products include ags0031 for metastatic renal cell carcinoma. Ca, an investment chat community for canadas small cap markets. The financial results could have an impact on the direction of trade of the stock, depending on its outcome.
Argos therapeutics is a biopharmaceutical company which focused on the development and commercialization of fully personalized immunotherapies for the treatment of. Argos therapeutics biomanufacturing facility, research triangle. Aug 16, 2017 aug 16 reuters argos therapeutics inc argos therapeutics inc files for possible resale up to 18. Aligos curative health care and medical treatment care. Argos further stated in the filing that it is not currently in compliance with the audit committee requirement as a result of the resignation of dr. About argos therapeutics argos therapeutics is an immunooncology company focused on the development and commercialization of fully personalized immunotherapies for. By continuing to use this website you agree to our use of cookies. Find out what works well at argos therapeutics from the people who know best. Notice has been received that the above companys revised second amended joint. Survival with ags003, an autologous dendritic cellbased. Argos therapeutics company profile office locations. Scopri i dettagli delle offerte di lavoro presso argos therapeutics, inc. The durham company disclosed in its annual report filed with the sec on thursday that it does not have.
Argos therapeutics faces threat of delisting triangle. This plan has a brightscope rating of 88, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for company generosity, participation rate, and salary deferral. It is particularly attractive for combination therapy with a novel. Argos therapeutics reports fourth quarter and full year 2017 financial results and operational highlights.
Salaries posted anonymously by argos therapeutics employees. There are many opportunities to learn, and management is decent in most departments. A link to download a pdf version of the drug profile will be included in your email receipt. Aug 16 reuters argos therapeutics inc argos therapeutics inc files for possible resale up to 18. Argos therapeutics to discuss automated manufacturing process. Get the inside scoop on jobs, salaries, top office locations, and ceo insights. The company is focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform. The achieve success in such a dynamic biotechnology industry across various countries is to diversify the systematic risks of political environment. Briefargos therapeutics files for possible resale up to.
A free inside look at argos therapeutics salary trends based on 12 salaries wages for 12 jobs at argos therapeutics. Argos therapeutics, argos and arcelis, the argos therapeutics logo and other trademarks or service marks of argos appearing in this quarterly report on form 10q are the property of argos. All content is posted anonymously by employees working at argos therapeutics. Argos therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its arcelis technology platform. As of 05032020, average assets is likely to grow to about 42. Argos therapeutics revenue per employee is relatively stable at the moment as compared to the last year. Argos therapeutics shares halted news pending paul quintaro thu, 19 apr 2018 06. Uncover why argos therapeutics is the best company for you. Argos therapeutics is a small company where everyone knows everyone else. The company is also pursuing novel therapeutic agents aimed at activation of.
1366 1382 199 341 1419 488 259 1353 1681 1037 1563 418 910 1015 504 1489 522 1439 429 1261 871 944 779 850 383 137 654 1146 322 478 44 1677 1566 1225 1168 1289 635 126 815 538